P4HA1 mediates YAP hydroxylation and accelerates collagen synthesis in temozolomide-resistant glioblastoma

Xueru Li1, Gangfeng Yu2,3, Xiao Zhong1

  • 1Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Key Laboratory of Major Brain Disease and Aging Research (Ministry of Education), Chongqing Medical University, Chongqing 404100, China.

PubMed
Abstract

Insights

Glioblastoma cells resist temozolomide by increasing collagen type I via the P4HA1-YAP pathway. Targeting this axis enhances chemoresistance and improves survival in glioblastoma models.

Area of Science:

  • Oncology
  • Cancer Biology
  • Molecular Mechanisms

Background:

  • Temozolomide (TMZ) resistance is a major hurdle in glioblastoma (GBM) treatment.
  • Collagen remodeling is implicated in therapy resistance across various cancers.
  • Understanding GBM's collagen reprogramming mechanisms is crucial for overcoming chemoresistance.

Purpose of the Study:

  • To investigate how GBM cells reprogram collagens to develop TMZ chemoresistance.
  • To elucidate the molecular pathways involved in collagen accumulation in GBM.
  • To assess the therapeutic potential of targeting collagen regulators in GBM.

Main Methods:

  • Analysis of collagen in patient samples and GBM murine models.
  • In vitro studies using human and mouse GBM cell lines.
  • RNA-sequencing, ChIP, IP-MS, and co-IP assays to identify molecular mechanisms.
  • In vitro and in vivo experiments to evaluate P4HA1 and YAP roles in TMZ sensitivity.

Main Results:

  • TMZ exposure increased collagen type I (COL I) expression in GBM.
  • Collagen accumulation enhanced GBM cell survival and TMZ resistance.
  • P4HA1 stabilized YAP by preventing its degradation, promoting COL1A1 transcription and collagen deposition.
  • Disrupting the P4HA1-YAP axis reduced COL I, sensitized cells to TMZ, and improved survival in mice.

Conclusions:

  • P4HA1 drives YAP-mediated COL1A1 transcription, leading to collagen accumulation.
  • This collagen accumulation promotes chemoresistance in glioblastoma.
  • Targeting the P4HA1-YAP axis offers a potential strategy to overcome TMZ resistance in GBM.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K